Albert Health
Albert Health is an evidence-based multi-chronic disease management platform that leverages AI. Our mission is to improve treatment adherence and increase the quality of life of patients.
Founded in the UK in 2018, our company has received a total investment of approximately $1.5m from international investors such as Techstars, Wayra and SabancıVentures. As of 2023, with a mission to expand our global footprint, we have started to strengthen our presence in the MENA region. Our product is now available in Arabic, English and Turkish as a result of our global programmes.
We co-create disease-specific programmes with pharmaceutical companies & insurers to increase medication adherence and the quality of life of patients. So far, we have reached the lives of more than 200.000 patients through our programmes with partners Roche, Pfizer, Bayer, Sanofi and more in metabolic diseases, oncology, neurology and cardiology.
We are helping patients with AI-based personalised coaching, disease management, and telehealth. By using voice technology, we are able to reach patients from all ages and socio-economical levels.
albert.health
Associated Albert Health Articles
INCREASING TREATMENT ADHERENCE IN CHRONIC DISEASES
Recai Serdar Gemici, co-founder & CEO Albert Health,on the importance of personalised programmes for everyone As populations become older through the world, chronic diseases are becoming more prevalent. Often they exist in tandem with other co-morbidities, creating a...
